Detection of psilocin in body fluids

Similar documents
Screening by immunoassay and confirmation & quantitation by GC-MS of buprenorphine and norbuprenorphine in urine, whole blood and serum

Rapid and Robust Detection of THC and Its Metabolites in Blood

ANALYSIS OF -HYDROXYBUTYRATE (GHB) AND -BUTYROLACTONE (GBL) IN LIQUIDS PERFORMED AT NATIONAL LABORATORY OF FORENSIC SCIENCE (SKL), SWEDEN

The Development of LC/MS Methods for Determination of MDMA (Ecstasy) and Metabolites in Biological Samples

Screening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System

BENZODIAZEPINE FINDINGS IN BLOOD AND URINE BY GAS CHROMATOGRAPHY AND IMMUNOASSAY

[application note] Simultaneous detection and quantification of D 9 THC, 11-OH-D 9 T H C and D 9 THC-COOH in whole blood by GC tandem quadrupole MS

Possibility of Use a Saliva for Determination Ethanol and Opiates

Determination of red blood cell fatty acid profiles in clinical research

PHOTOCATALYTIC DECONTAMINATION OF CHLORANTRANILIPROLE RESIDUES IN WATER USING ZnO NANOPARTICLES. DR. A. RAMESH, Ph.D, D.Sc.,

High Throughput Extraction of Opiates from Urine and Analysis by GC/MS or LC/MS/MS)

Extraction of 11-nor-9-carboxy-tetrahydrocannabinol from Hydrolyzed Urine by ISOLUTE. SLE+ Prior to GC/MS Analysis

The Development of LC/MS Methods for Determination of Polar Drugs of Abuse in Biological Samples

IMPORTANCE OF Q UANTITATIVE ESTIM ATIO N OF OPIATES AND C ANN ABIN OIDES FOR DETERM INATIO N OF DR IVIN G PERFORMANCE

Eszopiclone (Lunesta ): An Analytical Profile

Supplementary Information

PHARMACOKINETIC STUDY OF DEXTROMETHORPHAN WITH URINARY EXCRETION

New Automated Screening System for the Determination of Basic Compounds in Urine by On-Line Extraction-HPLC- DAD

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

Chromatography Vacuum Ultraviolet Spectroscopy

Analysis of several common. organic acids in tobacco leaf, snus, and moist snuff

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Determination of Bath Salts (Pyrovalerone Analogs) in Biological Samples

Application. Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS. Introduction. Authors. Abstract. Forensic Toxicology

Determination of taurine in energy drinks by high-performance liquid chromatography

LC/MS/MS Analysis of Metabolites of Synthetic Cannabinoids JWH-018 and JWH-073 in Urine

Improving Benzodiazepine Immunoassay Sensitivity by Rapid Glucuronide Hydrolysis Technology

A unique tool for metabolite research Q Exactive GC coupled with IRMS (QE GC-IRMS)

ARTIFACT FORMATION DUE TO ETHYL THIO-

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

Application Note. Abstract. Authors. Pharmaceutical

Determination of Opiates and Metabolites in Blood Using Electrospray LC/MS. Application Note

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

Fatty Acid Mass Spectrometry Protocol Updated 10/11/2007 By Daren Stephens

SELECTRA-SIL DERIVATIZING REAGENTS

Correlation of some Drugs of Abuse in Human Urine by EMIT and GC/MS Analysis

LAURA S. WATERS JASON G. LINVILLE, COMMITTEE CHAIR ELIZABETH A. GARDNER RAY H. LIU A THESIS

Analyze Drugs of Abuse with Agilent J&W Ultimate Plus Tubing in an Inert Flow Path

Determination of codeine and morphine in Brown Mixture (opium preparations) in Taiwan using SPE and GC/MS

3-Acetyldeoxynivalenol. 15-Acetyldeoxynivalenol

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

Metabolomics Strategies

Evaluation of Acetylcodeine as a Specific Marker of Illicit Heroin in Human Hair

C. Randall Clark* and Jack DeRuiter. F. Taylor Noggle. Abstract. Introduction

Quantitative Analysis of -Hydroxybutyrate in Hair Using Target Analyte Finding Processing of Comprehensive GC-HRT Data

Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System

Fast determination of residual glycerol and glycerides in biodiesel by SFC/MS using the Agilent 1260 Infinity Analytical SFC System

Detection of Low Level of Chloramphenicol in Milk and Honey with MIP SPE and LC-MS-MS

DIRECT EXTRACTION OF BENZODIAZEPINE METABOLITE WITH SUPERCRITICAL FLUID FROM WHOLE BLOOD

Analysis of the fatty acids from Periploca sepium by GC-MS and GC-FID

(2Z,7Z)-Cycloocta-2,7-dienone 4

Analyze Barbiturates in Urine with Agilent 6430 LC/MS/MS and Poroshell 120 EC-C18

Determination of Amantadine Residues in Chicken by LCMS-8040

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Urine Using UHPLC-TOF

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Automated Sample Preparation for Profiling Fatty Acids in Blood and Plasma using the Agilent 7693 ALS

AS Application Note 1602

S. George* and R.A. Braithwaite Regional Laboratory for Toxicology, City Hospital NHS Trust, Dudley Road, Birmingham, England, B 18 7QH.

Measuring Phytosterols in Health Supplements by LC/MS. Marcus Miller and William Schnute Thermo Fisher Scientific, San Jose, CA, USA

Analysis and Quantitation of Cocaine on Currency Using GC-MS/MS. No. GCMS No. SSI-GCMS-1501

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

COMA AFTER INTAKE OF GAMMA-HYDROXYBUTYRIC ACID (GHB): TWO CASE REPORTS

METHOD FOR THE DETERMINATION OF - DICARBONYL COMPOUNDS OF WINE BY GC AFTER DERIVATIZATION BY 1,2-DIAMINOBENZENE (OIV-Oeno 386B-2010)

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

SUPPLEMENTARY INFORMATION. Materials and Methods

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

2D-LC as an Automated Desalting Tool for MSD Analysis

Determination and pharmacokinetics of manidipine in human plasma by HPLC/ESIMS

CHAPTER-6 IDENTIFICATION, AND CHARACTERISATION OF DEGRADATION IMPURITY IN VALSARTAN TABLETS

DETERMINATION OF FATTY ACIDS IN EDIBLE OILS BY CAPILARY GC

Authors. Abstract. Introduction. Environmental

Determination of Selected Illegal Drugs and its Important Metabolites in Waste Water by Large Volume Direct Injection HPLC-MS/MS

Detection of Morphine in Blood and Urine Samples from Horses Administered Poppy Seeds and Morphine Sulfate Orally

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Automated Sample Preparation for FAME Analysis in Edible Oils Using an Agilent 7696A Sample Prep WorkBench

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Product Guide for LudgerSep TM ur2 UHPLC Column for DMB Sialic Acid Analysis

Lutein Esters from Tagetes Erecta

Rapid Analysis of 37 FAMEs with the Agilent 8860 Gas Chromatograph

Product Guide for LudgerSep TM R1 HPLC Column for DMB labelled Sialic Acid Analysis

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Have A Nice Tryptamine. Brian Waters LA County Coroner CAT San Francisco June, 2006

Application Note. Author. Abstract. Introduction. Food Safety

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Rapid Hydrolysis of Benzodiazepines in Urine. Alicia Zook 1 and Crystal Xander B.S. 2. Cedar Crest College, Allentown, PA 1

Application of LC/Electrospray Ion Trap Mass Spectrometry for Identification and Quantification of Pesticides in Complex Matrices

SUPPLEMENTARY INFORMATION

Concentrating Alpha-tocopherol from Oil Byproduct with Supercritical Methanol and CO 2

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

S.O.P. : ARO/458 Title: Analysis of zeranol and metabolites in urine, Page : 1 of 9 bile, meat, liver and kidney by GC-MS Revision : 0 Date :

Technical Report. Sugar and Sterol Analysis in Human Body Fluids on a True Dual Column GCMS System. 1. Summary. 2. Introduction

A Rapid Method for Detection of Drugs of Abuse in Blood Samples Using the Thermal Separation Probe and the 5975T LTM GC/MS

Zolpidem in lethal cases

Automated Purification and Analytical Reinjection of a Small Molecule Drug, Probenecid, on a Gilson LC/MS Dual Function System

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

Transcription:

Forensic Science International 113 (2000) 403 407 www.elsevier.com/ locate/ forsciint Detection of psilocin in body fluids G. Sticht *, H. Kaferstein Institute of Forensic Medicine, University of Cologne, Melatengurtel 60-62, D-50823 Koln, Germany Abstract Active compounds of some mushrooms e.g. Psilocybe cubensis, Paneolus subalteatus or Stropharia coronilla, the psychotropic agents psilocybin and psilocin, have hallucinogenic effects. In one case of magic mushroom intake, we had to analyse blood and urine. Psilocin was detected in the urine with REMEDi HS. Most of the psilocin was excreted as the glucuronide. Therefore an enzymatic hydrolysis should be the first step in analysis. Free psilocin was determined at a concentration of 0.23 mg/l while the total amount was 1.76 mg/l urine. The concentration of psilocin in serum was too low for detection with REMEDi HS. We proved a GC MS-method with d3-morphine as internal standard and silylation with MSTFA. Similarly to urine, most of the psilocin in serum was found in the conjugated form. The concentration of free psilocin was 0.018 mg/ l, that of total psilocin, 0.052 mg/ l serum. 2000 Elsevier Science Ireland Ltd. All rights reserved. Keywords: Psilocin; Psilocybin; Body fluids; Magic mushrooms 1. Introduction be assumed that psilocin is similar to morphine glucuronidated to a high degree. Additionally In recent years so called magic mushrooms play psilocin should have comparable extraction propa growing role among controlled substances. For erties as morphine because of the presence of a instance, the species Psilocybe cubensis is offered as phenolic and a tertiary amino group. Symptoms after a set for cultivation (Fig. 1). At a corresponding time intake of psilocybin containing mushrooms can be of the year in our region, mushrooms like Paneolus very pronounced as the following example demsubalteatus or Stropharia coronilla can be collected onstrates. [1]. Active components are the psychotropic substances psilocybin and psilocin (Fig. 4). The content of psilocybin is normally far higher than that of psilocin which does not have the protecting phosphorous 2. Case report ester group in its molecule. The mushrooms Two young male people drove from Cologne to are consumed because of their hallucinogenic effects. The Netherlands to buy narcotic drugs. Among They are illegal drugs with no accepted medical use others, mushrooms were offered. Each of the men but a high abuse potential (schedule I controlled consumed 4 to 5 g of mushrooms. Subsequently they substances). A rapid dephosphorylation of psilocybin doubled up with laughter. Sometime later the house to psilocin takes place in the organism [2], and it can wall seemed to come up to the persons. After the *Corresponding author. Tel.: 149-221-478-4291; fax: 149- effects had worn off and the persons felt fit again, 221-478-4261. they started homeward. During the trip on the 0379-0738/ 00/ $ see front matter 2000 Elsevier Science Ireland Ltd. All rights reserved. PII: S0379-0738(00)00213-9

404 G. Sticht, H. Kaferstein / Forensic Science International 113 (2000) 403 407 Fig. 1. In a journal, a set for cultivation of mushrooms was offered. highway the driver stopped his car because he turned Varian Bond Elut LRC Certify 300 mg per 10-ml sick. Then policemen came, confiscated the rest of columns (Phenomenex/ Hosbach) Reagent Kit and the drugs and forbade further driving of the car. other supplies for drug determination with REMEDi Twenty min later the policemen observed the car HS. again but with insecure driving and they stopped it. The reaction ability of both occupants was retarded, 3.2. Instrumentation stability in standing was insecure and the eyes were glassy and reddened. Two h later, 5 to 6 h after REMEDi HS drug profiling system (Bio-Rad). consuming the mushrooms, the doctor taking blood Hewlett-Packard 5995A gas chromatograph/ mass noted the following observations concerning the spectrometer connected to a 59970A Workstation. driver: insecure and sluggish walk, inarticulate Split ratio, 1:10. Injector temperature, 2508C; detecspeech, strongly enlarged pupils, delayed pupillary tor temperature 2008C, and the oven temperature was reaction, dazed consciousness, retarded behaviour, programmed from 2008C at 58C/ min to 2508C. An depressive mood, illogical thinking, slight problems HP Ultra-1 capillary column (12 m30.2 mm I.D.3 of naming time and local position. 0.33 mm film thickness) was used. Carrier gas: helium 5.0. 3. Experimental 3.3. Performance of analysis 3.1. Reagents 3.3.1. REMEDi One ml of urine was prepared as recommended for Psilocin (100 mg/ ml methanol) was obtained from drug analysis with REMEDi HS. Cleavage of the Sigma Aldrich. d3-morphine was synthesised in our glucuronide in a second sample was performed in a laboratory. water bath at 458C during 1 h after addition of 10 ml b-glucuronidase from E. coli K 12 (Boehringer/ of glucuronidase solution. Mannheim). MSTFA (N-Methyl-N-trimethylsilyltrifluoroaceta- 3.3.2. GC MS mide) (MachereyNagel/ Duren). A solution of 25 ng of d3-morphine in 40 ml

G. Sticht, H. Kaferstein / Forensic Science International 113 (2000) 403 407 405 methanol was added to 0.5 ml of serum or urine, to a The retention indices were calculated to 2099 for parallel sample, additionally 10 ml of glucuronidase psilocin-di-tms and 2520 for d3-morphine-di-tms. solution for hydrolysis of the glucuronide as described above. The samples were diluted with 5 ml of phosphate buffer ph 8. Column conditioning: the following solutions were 4. Results aspirated through Varian Certify LRC 300-mg columns: 2 ml of methanol, 2 ml of phosphate buffer The calibration ranges were from 1 to 10 ng ph 8. Sample addition: the prepared samples were psilocin and d3-morphine as di-tms-derivatives aspirated through the columns at 1 to 2 ml/min until corresponding to concentrations of 10 to 100 ng/ml the columns went to dryness. serum or urine. There was linearity within these 2 Column wash: 2 ml water, 2 ml acetate buffer ph ranges (R.0.99). Recoveries of psilocin and d3-4, 2 ml methanol/ water (30% v/ v). The columns morphine after addition of 25 ng/ ml to 0.5 ml serum were then dried under vacuum for 2 min. were nearly complete. Recovery of psilocin related Sample elution: the elution was performed with to d3-morphine as internal standard amounted to methanol/conc. ammonium hydroxide (9812 v/v) at 98% with a standard deviation of 12% (n53). The slight vacuum, first with 2 ml and then with 1 ml. limit of detection was about 5 ng/ml serum. Derivatization: The solution was evaporated under After a conceded intake of Psilocybe cubensis nitrogen at 408C and after addition of 50 ml MSTFA blood and urine were available for investigation. the tube was closed with parafilm and heated for 15 Using REMEDi HS drug profiling system psilocin min at 808C. could be detected in urine. By GC MS analysis in The injection volume was 10 ml. The detector was both body fluids psilocin was detectable. In urine a used in the electron impact mode (El) at 70. Mass complete mass spectrum was to achieve as Fig. 2 spectra were recorded in the mass range of m/z demonstrates. The library search of the system led to 50 550. psilocybin but it is considered that the phosphorous Qualitative and quantitative analyses were per- ester group is cleaved by the derivatization reaction. formed using single-ion monitoring (SIM) mode by Fig. 3 shows ion chromatograms of the serum comparison of retention times and relative abundance sample. The characteristic mass peaks 290, 291, and of three ions (psilocin-di-tms 290, 291, 348) resp. 348 of psilocin-di-tms are present at a retention four ions (d -morphine-di-tms 404, 417, 432, 433). time of 4.54 min in expected relative intensities. 3 Fig. 2. Comparison of mass spectra of psilocybin-tms-derivative and of a compound from an urine extract.

406 G. Sticht, H. Kaferstein / Forensic Science International 113 (2000) 403 407 Fig. 3. Ion chromatograms of a serum extract (psilocin-di-tms derivative marked with an arrow). The following concentrations were measured maximum plasma levels, 105 resp. 1.9 min [2]. (Table 1). Hasler et al. [2] found peak plasma levels of 8.262.8 ng/ ml psilocin after oral administration of 0.22460.02 mg/ kg (10 20 mg) psilocybin. Our 5. Discussion investigations demonstrate that psilocin can be detected in body fluids after consumption of corre- Keller et al. [3] have recently described a GC sponding mushrooms. Glucuronidation seems to be MS-method for the detection of psilocin in mush- an important detoxification step (Fig. 4). In the rooms after derivatization with MSTFA. In our presented case, the free part of psilocin in serum is procedure for estimation of morphine and benzoylec- 35% and in urine only 13%. Similar high parts of gonine, we use the same derivatization technique [4]. bound psilocin in blood, urine and bile of two Protection of the two polar groups of psilocin, a individuals are referred by Wennig [5]. phenolic and a NH-group, by trimethylsilyl (TMS) The REMEDi HS system is suitable for screening may avoid thermal decomposition. The structure of of urine for psilocin. But in spite of an expected psilocin di-tms is confirmed by the occurrence of obviously higher yield a general enzymatic hydrolthe molecular peak m/z 348 and the typical fragment ysis is not to recommended because by far more m/z 290 formed by loss of m/z 58 in the mass interfering substances appear in the chromatogram spectrum. which can overlap the internal standard 1. Psilocybin, the main active component of magic In serum, not even after hydrolysis concentration mushrooms is transformed into psilocin by rapid of psilocin is high enough for a detection with dephosphorylation which is indicated by a short REMEDi HS and therefore GC MS analysis is the period between oral and a very short interval between intravenous administration of psilocybin and method of choice. Extraction and derivatization are successful in the same way as with morphine. Psilocin can be detected therefore by the procedure used for opiate and Table 1 cocaine detection without problems. Morphine or Psilocin concentrations in serum and urine after consumption of magic mushrooms deuterated morphine can serve as internal standards because of similarities with psilocin in the structure Serum Urine and properties in the extraction procedure. For Psilocin (free) (mg/ l) 0.018 0.23 screening of blood or urine with GC MS an en- Psilocin (total) (mg/ l) 0.052 1.76 zymatic hydrolysis is recommended because the

G. Sticht, H. Kaferstein / Forensic Science International 113 (2000) 403 407 407 detectable amounts of psilocin increase remarkably by this procedure. References [1] A. Bresinsky, H. Besl, Giftpilze mit einer Einfuhrung in die Pilzbestimmung, in: Wissenschaftliche Verlagsgesellschaft mbh, Stuttgart, 1985, pp. 112 118. [2] F. Hasler, D. Bourquin, R. Brenneisen, T. Bar, F.X. Vollenweider, Determination of psilocin and 4-hydroxyindole-3- acetic acid in plasma by HPLC ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man, Pharm. Acta. Helv. 72 (1997) 175 184. [3] T. Keller, A. Schneider, P. Regenscheit, R. Dimliofer, T. Rucker, J. Jaspers et al., Analysis of psilocybin and psilocin in Psilocybe subcubensis GUZMAn by ion mobility spectrometry and gas chromatography mass spectrometry, For. Sci. Int. 99 (1999) 93 105. [4] H. Kaferstein, G. Sticht, Immunchemische und gaschromatographisch massenspektrometrische Befunde im Blut bei Verdacht auf Drogenkonsum-1. Mitteilung: Opiate Kokain, Cannabis und Amphetamine, Rechtsmed 8 (1998) 173 177. [5] R. Wennig, Personal communication (1999). Fig. 4. Structures of psilocybin, psilocin and psilocin glucuronide.